Ko, Chanyoung
Kang, Soyeon
Hong, Soon-Beom
Park, Yu Rang
Funding for this research was provided by:
Korean Health Industry Development Institute
Article History
Received: 2 June 2023
Accepted: 22 June 2023
First Online: 15 August 2023
Declarations
:
: The authors declare no competing interests.
: The study is approved by the Seoul National University Hospital IRB Review Board (IRB No. H-2210-137-1374). The study will be conducted in accordance with the Helsinki Declaration 1964, including subsequent revisions. Informed consent will be obtained from all the participants and their legal guardians involved in the study. The participants and their legal guardians may, at any time, choose to withdraw from the study without being required to explain and without affecting the person’s future treatment. The study investigators are under the impression that the questionnaires, interviews, videorecording tasks, and other data acquisition methods will not lead to any lasting discomfort for the participants. There are no known expected short- or long-term risks associated with the present study.
: Not applicable.
: Funding was provided by a grant from the MD-PhD Physician-Scientist Training Program from the Korean Health Industry Development Institute (KHIDI), Ministry of Health and Welfare of the Republic of Korea. This work was also supported by the Korean Ministry of Science and Information and Communication Technology Institute via Institute of Information & communications Technology Planning & Evaluation (IITP) grant (No. 2022-0-00234, ‘Development of digital therapeutics for improvement of social interaction skills in patients with autism spectrum disorder’).